Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy (Q33144725)

22 July 2017

title

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy (English)

1 reference

hypertrophic cardiomyopathy

22 July 2017

0 references

1 reference

1 reference

inferred from title

ventricular tachycardia

1 reference

Elliott PM

1

1 reference

22 July 2017

Sharma S

2

1 reference

22 July 2017

Varnava A

3

1 reference

22 July 2017

Poloniecki J

4

1 reference

22 July 2017

Rowland E

5

1 reference

22 July 2017

McKenna WJ

6

1 reference

22 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

Journal of the American College of Cardiology

22 July 2017

published in

1 reference

22 July 2017

volume

33

1 reference

22 July 2017

issue

6

1 reference

22 July 2017

page(s)

1596-1601

1 reference

The management of hypertrophic cardiomyopathy

22 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Mechanisms of exercise limitation in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Hypertrophic cardiomyopathy and sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

The automatic implantable cardioverter-defibrillator in young patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Hypertrophic cardiomyopathy: role of the implantable cardioverter-defibrillator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

The Value of Electrophysiology Study and Prophylactic Implantation of Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

10.1016/S0735-1097(99)00056-X

Identifiers

DOI

1 reference

22 July 2017

1 reference